PRT-060318 (dihydrochloride)
PRT-060318 (PRT318) dihydrochloride is a potent, selective and orally active tyrosine kinase Syk inhibitor with an IC50 of 3 nM. PRT-060318 dihydrochloride suppresses chronic lymphocytic leukemia (CLL) B cell activation and migration, and induces apoptosis. PRT-060318 dihydrochloride prevents Heparin -induced thrombocytopenia and thrombosis in a transgenic mouse model. PRT-060318 dihydrochloride can be used for CLL and thrombus research[1][2].
Product Specifications
CAS Number
3032567-93-1
Product Name Alternative
PRT318 (dihydrochloride)
UNSPSC
12352005
Target
Apoptosis; Syk
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Inflammation/Immunology
Purity
98.98
Smiles
O=C(C1=CN=C(N[C@H]2[C@@H](N)CCCC2)N=C1NC3=CC=CC(C)=C3)N.Cl.Cl
Molecular Formula
C18H26Cl2N6O
Molecular Weight
413.34
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Filaggrin (Keratinocyte Differentiation Marker) (FLG/1561), CF640R conjugate, 0.1mg/mL
